Efficacy and safety of oral gepotidacin in the treatment of uncomplicated urinary tract infection: results of two randomized, multicentre Phase 3 trials (EAGLE-2 and EAGLE-3)

被引：0
|
作者：
Wagenlehner, Florian [1 ]
Perry, Caroline R. [2 ]
Hooton, Thomas M. [3 ]
Scangarella-Oman, Nicole E. [2 ]
Millns, Helen [4 ]
Feng, Hwa-ping [2 ]
Powell, Marcy [2 ]
Jarvis, Emily [4 ]
Dennison, Jeremy [5 ]
Sheets, Amanda [2 ]
Butler, Deborah [2 ]
Breton, John [2 ]
Janmohamed, Salim [5 ]
机构：
[1] Justus Liebig Univ, Giessen, Germany
[2] GSK, Collegeville, PA USA
[3] Univ Miami, Miami, FL USA
[4] GSK, Stevenage, Herts, England
[5] GSK, Brentford, England
来源：
JAC-ANTIMICROBIAL RESISTANCE | 2023年 / 5卷
关键词：
D O I：
10.1093/jacamr/dlad077.035
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P31
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of oral gepotidacin in the treatment of uncomplicated urinary tract infection: results of two randomized, multicentre Phase 3 trials (EAGLE-2 and EAGLE-3)
    Wagenlehner, Florian
    Perry, Caroline R.
    Hooton, Thomas M.
    Scangarella-Oman, Nicole E.
    Millns, Helen
    Feng, Hwa-Ping
    Powell, Marcy
    Jarvis, Emily
    Dennison, Jeremy
    Sheets, Amanda
    Butler, Deborah
    Breton, John
    Janmohamed, Salim
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 : III19 - III20
  • [2] Efficacy and safety of oral gepotidacin in the treatment of uncomplicated urinary tract infection: results of two randomized, multicentre Phase 3 trials (EAGLE-2 and EAGLE-3)
    Wagenlehner, Florian
    Perry, Caroline R.
    Hooton, Thomas M.
    Scangarella-Oman, Nicole E.
    Millns, Helen
    Feng, Hwa-Ping
    Powell, Marcy
    Jarvis, Emily
    Dennison, Jeremy
    Sheets, Amanda
    Butler, Deborah
    Breton, John
    Janmohamed, Salim
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (SUPP3):
  • [3] Efficacy and Safety of Oral Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection: Results of Two Randomised, Multicentre Phase 3 Trials (EAGLE-2 and EAGLE-3)
    Wagenlehner, Florian
    Perry, Caroline
    Hooton, Thomas M.
    Scangarella-Oman, Nicole E.
    Millns, Helen
    Feng, Hwa-ping
    Powell, Marcy
    Jarvis, Emily
    Dennison, Jeremy
    Sheets, Amanda
    Butler, Deborah
    Breton, John
    Janmohamed, Salim
    INNERE MEDIZIN, 2024, 65 : S69 - S69
  • [4] Gepotidacin Efficacy in E. coli Drug-Resistant Phenotypes: A Pooled Analysis of the EAGLE-2 and EAGLE-3 Randomized Controlled Trials in Uncomplicated Urinary Tract Infection
    Wagenlehner, Florian
    Hooton, Thomas M.
    Perry, Caroline
    Janmohamed, Salim
    Sheets, Amanda
    Dennison, Jeremy
    Millns, Helen
    Jarvis, Emily
    Scangarella-Oman, Nicole E.
    Huang, Chun
    INNERE MEDIZIN, 2024, 65 : S68 - S68
  • [5] Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials
    Wagenlehner, Florian
    Perry, Caroline R.
    Hooton, Thomas M.
    Scangarella-Oman, Nicole E.
    Millns, Helen
    Powell, Marcy
    Jarvis, Emily
    Dennison, Jeremy
    Sheets, Amanda
    Butler, Deborah
    Breton, John
    Janmohamed, Salim
    LANCET, 2024, 403 (10428): : 741 - 755
  • [6] Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study
    Perry, Caroline R.
    Scangarella-Oman, Nicole E.
    Millns, Helen
    Flight, William
    Gatsi, Sally
    Jakielaszek, Charles
    Janmohamed, Salim
    Lewis, David A.
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (09) : 2307 - 2320
  • [7] Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study
    Caroline R. Perry
    Nicole E. Scangarella-Oman
    Helen Millns
    William Flight
    Sally Gatsi
    Charles Jakielaszek
    Salim Janmohamed
    David A. Lewis
    Infectious Diseases and Therapy, 2023, 12 : 2307 - 2320
  • [8] Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea: nucleic acid amplification testing (NAAT) outcomes in a randomised, multicentre Phase 3 trial (EAGLE-1)
    Flight, W. G.
    Wilson, J. D.
    Lewis, D. A.
    Ross, J. D. C.
    Gatsi, S.
    Scangarella-Oman, N. E.
    Jakielaszek, C.
    Lythgoe, D.
    Janmohamed, S.
    Absalon, J.
    Perry, C. R.
    SEXUAL HEALTH, 2024, 21 (04) : 49 - 49
  • [9] Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis)
    Overcash, J. Scott
    Tiffany, Courtney A.
    Scangarella-oman, Nicole E.
    Perry, Caroline R.
    Tao, Yu
    Hossain, Mohammad
    Barth, Aline
    Dumont, Etienne F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)
  • [10] Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants
    Perry, Caroline
    Hossain, Mohammad
    Powell, Marcy
    Raychaudhuri, Aparna
    Scangarella-Oman, Nicole
    Tiffany, Courtney
    Xu, Sherry
    Dumont, Etienne
    Janmohamed, Salim
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (06) : 2297 - 2310
12345